Reference
1. Huang C, Wang Y, Li X et al. Clinical features of patients infected
with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395 : 497-506.
2. Zhu N, Zhang D, Wang W et al. A Novel Coronavirus from Patients with
Pneumonia in China, 2019. N Engl J Med 2020; 382 :
727-33.
3. Guan WJ, Ni ZY, Hu Y et al. Clinical Characteristics of Coronavirus
Disease 2019 in China. N Engl J Med 2020.
4. Shi H, Han X, Jiang N et al. Radiological findings from 81 patients
with COVID-19 pneumonia in Wuhan, China: a descriptive study.Lancet Infect Dis 2020.
5. M C, A B, X M et al. CT Imaging Features of 2019 Novel Coronavirus
(2019-nCoV). Radiology 2020; 295 : 202-7.
6. Fang Y, Zhang H, Xie J et al. Sensitivity of Chest CT for COVID-19:
Comparison to RT-PCR. Radiology 2020: 200432.
7. Linton NM, Kobayashi T, Yang Y et al. Incubation Period and Other
Epidemiological Characteristics of 2019 Novel Coronavirus Infections
with Right Truncation: A Statistical Analysis of Publicly Available Case
Data. J Clin Med 2020; 9 .
8. Kobayashi T, Jung SM, Linton NM et al. Communicating the Risk of
Death from Novel Coronavirus Disease (COVID-19). J Clin Med 2020;9 .
9. Yang S, Cao P, Du P et al. Early estimation of the case fatality rate
of COVID-19 in mainland China: a data-driven analysis. Ann Transl
Med 2020; 8 : 128.
10. Lin L, Li TS. [Interpretation of ”Guidelines for the Diagnosis and
Treatment of Novel Coronavirus (2019-nCoV) Infection by the National
Health Commission (Trial Version 5)”]. Zhonghua Yi Xue Za Zhi2020; 100 : E001.
11. Zhang T, He Y, Xu W et al. Clinical trials for the treatment of
Coronavirus disease 2019 (COVID-19): A rapid response to urgent need.Sci China Life Sci 2020.
12. Zhang Q, Wang Y, Qi C et al. Clinical trial analysis of 2019-nCoV
therapy registered in China. J Med Virol 2020.
13. Cochrane Handbook for Systematic Reviews of Interventions.Online Kensaku 2014; 35 : 154-5.
14. Han H, Xie L, Liu R et al. Analysis of heart injury laboratory
parameters in 273 COVID-19 patients in one hospital in Wuhan, China.J Med Virol 2020.
15. Li K, Wu J, Wu F et al. The Clinical and Chest CT Features
Associated with Severe and Critical COVID-19 Pneumonia. Invest
Radiol 2020.
16. M Y, W Y, Z T et al. Association of radiologic findings with
mortality of patients infected with 2019 novel coronavirus in Wuhan,
China. PloS one 2020; 15 : e0230548.
17. Qin C, Zhou L, Hu Z et al. Dysregulation of immune response in
patients with COVID-19 in Wuhan, China. Clin Infect Dis 2020.
18. R Q, Y L, YH Z et al. Platelet-to-lymphocyte ratio is associated
with prognosis in patients with Corona Virus Disease-19. Journal
of medical virology 2020.
19. Shi Y, Yu X, Zhao H et al. Host susceptibility to severe COVID-19
and establishment of a host risk score: findings of 487 cases outside
Wuhan. Crit Care 2020; 24 : 108.
20. Tian S, Hu N, Lou J et al. Characteristics of COVID-19 infection in
Beijing. J Infect 2020.
21. W Z, Z Z, X X et al. Relation Between Chest CT Findings and Clinical
Conditions of Coronavirus Disease (COVID-19) Pneumonia: A Multicenter
Study. AJR American journal of roentgenology 2020: 1-6.
22. Wan S, Xiang Y, Fang W et al. Clinical features and treatment of
COVID-19 patients in northeast Chongqing. J Med Virol 2020.
23. Xie H, Zhao J, Lian N et al. Clinical characteristics of Non-ICU
hospitalized patients with coronavirus disease 2019 and liver injuryA
Retrospective study. Liver Int 2020.
24. Zhang G. Analysis of clinical characteristics and laboratory
findings of 95 cases of 2019 novel coronavirus pneumonia in Wuhan,
China: a retrospective analysis. Respiratory research 2020;21 .
25. Zhang JJ, Dong X, Cao YY et al. Clinical characteristics of 140
patients infected with SARS-CoV-2 in Wuhan, China. Allergy 2020.
26. Zheng C, Wang J, Guo H et al. Risk-adapted Treatment Strategy For
COVID-19 Patients. Int J Infect Dis 2020.
27. Wu J, Li W, Shi X et al. Early antiviral treatment contributes to
alleviate the severity and improve the prognosis of patients with novel
coronavirus disease (COVID-19). J Intern Med 2020.
28. To KK, Tsang OT, Leung WS et al. Temporal profiles of viral load in
posterior oropharyngeal saliva samples and serum antibody responses
during infection by SARS-CoV-2: an observational cohort study.Lancet Infect Dis 2020.
29. Xu YH, Dong JH, An WM et al. Clinical and computed tomographic
imaging features of novel coronavirus pneumonia caused by SARS-CoV-2.J Infect 2020.
30. Li YK, Peng S, Li LQ et al. Clinical and Transmission
Characteristics of Covid-19 - A Retrospective Study of 25 Cases from a
Single Thoracic Surgery Department. Curr Med Sci 2020.
31. Chen G, Wu D, Guo W et al. Clinical and immunologic features in
severe and moderate Coronavirus Disease 2019. J Clin Invest 2020.
32. Gao Y, Li T, Han M et al. Diagnostic Utility of Clinical Laboratory
Data Determinations for Patients with the Severe COVID-19. J Med
Virol 2020.
33. Liu KC, Xu P, Lv WF et al. CT manifestations of coronavirus
disease-2019: A retrospective analysis of 73 cases by disease severity.Eur J Radiol 2020; 126 : 108941.
34. Jin X, Lian JS, Hu JH et al. Epidemiological, clinical and
virological characteristics of 74 cases of coronavirus-infected disease
2019 (COVID-19) with gastrointestinal symptoms. Gut 2020.
35. Qian GQ, Yang NB, Ding F et al. Epidemiologic and Clinical
Characteristics of 91 Hospitalized Patients with COVID-19 in Zhejiang,
China: A retrospective, multi-centre case series. QJM 2020.
36. Goh KJ, Choong MC, Cheong EH et al. Rapid Progression to Acute
Respiratory Distress Syndrome: Review of Current Understanding of
Critical Illness from COVID-19 Infection. Ann Acad Med Singapore2020; 49 : 1-9.
37. Chen N, Zhou M, Dong X et al. Epidemiological and clinical
characteristics of 99 cases of 2019 novel coronavirus pneumonia in
Wuhan, China: a descriptive study. Lancet 2020; 395 :
507-13.
38. G L, BM H. Active smoking is not associated with severity of
coronavirus disease 2019 (COVID-19). European journal of internal
medicine 2020.
39. Wu C, Chen X, Cai Y et al. Risk Factors Associated With Acute
Respiratory Distress Syndrome and Death in Patients With Coronavirus
Disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med 2020.
40. Zhou Z, Zhao N, Shu Y et al. Effect of gastrointestinal symptoms on
patients infected with COVID-19. Gastroenterology 2020.
41. Wang D, Hu B, Hu C et al. Clinical Characteristics of 138
Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in
Wuhan, China. JAMA 2020.
42. Mehta P, McAuley DF, Brown M et al. COVID-19: consider cytokine
storm syndromes and immunosuppression. Lancet 2020.
43. Lin L, Lu L, Cao W, Li T. Hypothesis for potential pathogenesis of
SARS-CoV-2 infection–a review of immune changes in patients with
viral pneumonia. Emerg Microbes Infect 2020: 1-14.
44. Chen G, Wu D, Guo W et al. Clinical and immunologic features in
severe and moderate Coronavirus Disease 2019. Journal of Clinical
Investigation 2020.
Table 1. Characteristic of eligible studies.